期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

垂体泌乳素腺瘤发病机制及其诊治的研究进展 被引量：6

暂未订购
导出
摘要 垂体泌乳素腺瘤是腺垂体中最常见的分泌性腺瘤，约占垂体肿瘤的40％～60％，也是常见颅内肿瘤之一。近年来，随着相关学科的快速发展，垂体泌乳素腺瘤的发病机制及诊疗手段有了较大进展，现综述如下。
作者 李祥骥 王雄伟
机构地区 宜昌市中心人民医院神经外科
出处 《中国临床神经外科杂志》 2012年第8期508-510,共3页 Chinese Journal of Clinical Neurosurgery
关键词 垂体泌乳素腺瘤 发病机制 诊断 治疗 进展
分类号 R736.4 [医药卫生—肿瘤]
  • 相关文献

参考文献17

  • 1Chesnokova V, Zonis S, Rubinek T, et al. Senescence me- diates pituitary hypoplasia and restrains pituitary tumor growth [J]. Cancer Res, 2007, 67(21): 10564-10572.
  • 2Agarwal SK, Ozawa A, Mateo CM, et al. The MEN1 gene and pituitary tumours [J]. Horm Res, 2009, 71(Suppl2):131-138.
  • 3Yin Z, Williams-Smions L, Parlow AF, et al. Pituitary- specific knockout of the Carney complex gene prkarla leads to pituitary tumorigenesis [J]. Mol Endocrinol, 2008, 22(2): 380-387.
  • 4Labeur M, Paez-Pereda M, Haedo M, et al. Pituitary tumors: cell type-specific roles for BMP-4 [J]. Mol Cell Endocrinol, 2010, 326(1-2): 85-88.
  • 5Bottoni A, Piccin D, Tagliati F, et al. MiR-15a and miR- 16-1 down-regulation in pituitary adenomas [J]. J Cell Physiol, 2005, 204(1): 280-285.
  • 6施秀华,孙青芳.微小RNA与垂体腺瘤发病机制的相关研究进展[J].中国微侵袭神经外科杂志,2011,16(7):329-332. 被引量：4
  • 7Cakir M, Grossman AB. Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis [J]. Expert Opin Ther Targets, 2009, 13(9): 1121-1134.
  • 8Dworakowska D, Wlodek E, Leontiou CA, et al. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pitui- tary adenomas and their effects on downstream effectors [J]. Endocr Relat Cancer, 2009, 16(4): 1329-1338.
  • 9Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an endocrine society clini- cal practice guideline [J]. J Clin Endocrinol Metab, 2011, 96 (2): 273-288.
  • 10Iyer P, Molitch ME. Positive prolactin response to bromo-criptine in 2 patients with cabergoline-resistant prolactino- mas [J]. Endocr Pract, 2011, 17(3): E55-88.

二级参考文献30

  • 1傅佳峰,诸葛启钏.垂体泌乳素腺瘤的治疗进展[J].国际神经病学神经外科学杂志,2005,32(6):558-561. 被引量：14
  • 2Thorner M O.Prolactinoma In:Bardin CW,ed Current therapy in endocrinology and metabolism.4th ed Philadelphia:BC Deckerm, 1991:35-38.
  • 3王忠诚.工忠诚神经外科学.武汉:湖北科学技术出版社,2005:620-658.
  • 4曹泽毅.中华妇产科学(下册).2版.北京:人民卫生出版社,20()4:2442.
  • 5郁琦,王任值,金自孟.高泌乳素血症诊疗共识.北京:第六届实用妇科内分泌学习班,2009:205.
  • 6Lee RC, Feinbaum RL, Ambros V. The C.elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 [J]. Cell, 1993, 75(5): 843-854.
  • 7McDowell BD, Wallace RB, Camahan RM, et al. Demographic differences in incidence for pituitary adenoma [J]. Pituitary, 2010, 14(1): 23-30.
  • 8Ezzat S, Asa SL. Mechanisms of disease: the pathogenesis of pituitary tumors [J]. Nat Clin Pract Endocrinol Metab, 2006, 2(4): 220-230.
  • 9Cheng AM, Byrom MW, Shelton J, et ol. Antisense inhibi- tion of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis [J]. Nucleic Acids Res, 2005, 33(4): 1290-1297.
  • 10Bottoni A, Piccin D, Tagliati F, et al. MiR-15a and miR-16-1 down-regulation in piaxitary adenomas [J]. J Cell Physiol, 2005, 204(1): 280-285.

共引文献11

同被引文献51

  • 1吴哲褒,苏志鹏,于春江.侵袭性泌乳素腺瘤溴隐亭治疗后的迟发性耐药现象:5例报告[J].中华神经外科疾病研究杂志,2006,5(4):376-377. 被引量：8
  • 2王任直.神经外科学[M].2版.北京:人民卫生出版社,2002:338-341.
  • 3Cronier L, Crespin S, Strale PO, et al. Gap junctions and cancer: new functions for an old story [ J 5. Antioxid Redox Signal, 2009, 11 (2) :323-338. DOI:10. 1089/ars. 2008. 2153.
  • 4Lewis BM, Pexa A, Francis K, et al. Adenosine stimulates connexin 43 expression and gap junctional communication in pituitary folliculostellate cells [ J ]. FASEB J, 2006, 20 ( 14 ) : 2585-2587. DOI : 10. 1096/fj. 06-6121fie.
  • 5Vitale ML,Carding J, Gilula NB, et al. Dynamics of connexin 43 levels and distribution in the mink (mustela vison ) anterior pituitary are associated with seasonal changes in anterior pituitary prolactin content [ J ~. Biol Reprod, 2001,64 ( 2 ) : 625 ~533. DOI : 10. 1095/biolreprod64.2. 625.
  • 6Sagar GD, Larson DM. Carbenoxolone inhibits iunetional transfer and upregulates Cnnnexin43 expression by a protein kinase A- dependent pathway [ J ]. J Cell Binchem, 2006,98 ( 6 ) : 1543- 1551. DOI : 10. 1002/jcb. 20870.
  • 7Zhao W,Shen Y,Ren S. Endogenous expression of Neuregulin-1 as a potential modulator of prolactin secretion in GH3 cells[J]. Cell Tissue Res,2011,344(2) :313-320. DOI:10. 1007/s00441-011-1157-y.
  • 8Wang H,Zhang Y,Zhou A, et al. Effects of silencing connexin43 expression of pituitary tumor-transforming gene in prolactinomas [ J]. Neurol Res ,2015 ,37 (2) : 153-158. DOI : 10. 1179/1743132814Y. 0000000419.
  • 9Colao A. Pituitary tumours: the prolactinoma [ J J. Best l'ract lies Clin Endocfinol Metab ,2009,23 ( 5 ) : 575-596. DOI :/10. 1016/ j. beem. 2009.05. 003.
  • 10Lv H, Li C, Gui S, et al. Expression of estrogen receptor a and growth factors in human prolactinoma and its correlation with clinical features and gender [ J ]. J Endoerinol Invest, 2012,35 ( 2 ) : 174-180. DOI : 10. 3275/7607.

引证文献6

二级引证文献10

中国临床神经外科杂志
2012年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部